## Most Common Cause of TB Treatment Failure in RNTCP **Key Point:** Poor adherence to anti-TB therapy is the single most common cause of treatment failure in newly diagnosed smear-positive TB patients under RNTCP, accounting for the majority of non-cure outcomes. ### Epidemiological Context In the Indian TB control program, treatment failure rates are primarily driven by patient-level factors rather than drug-related or pathogen-related factors. Adherence is the critical modifiable determinant. ### Why Adherence Is the Leading Cause 1. **Lengthy treatment duration** — 6 months of intensive + continuation phase requires sustained compliance 2. **Adverse drug effects** — GI upset, hepatotoxicity, peripheral neuropathy drive patients to self-discontinue 3. **Social determinants** — poverty, migration, stigma, lack of supervision in non-DOT settings 4. **Asymptomatic phase** — patients feel better after 2–3 months and stop therapy ### RNTCP Strategy to Address Adherence | Intervention | Mechanism | | --- | --- | | Directly Observed Therapy (DOT) | Ensures pill-by-pill supervision | | Fixed-Dose Combinations (FDCs) | Reduces pill burden, simplifies regimen | | ASHA / ANM involvement | Community-level support and reminder | | Nutritional support | Mitigates side effects | **High-Yield:** RNTCP emphasizes DOT as the gold standard to overcome adherence barriers. Non-adherence → incomplete therapy → treatment failure → drug resistance (secondary MDR-TB). **Clinical Pearl:** A patient who defaults for >3 consecutive months is classified as "lost to follow-up" and is at high risk of developing MDR-TB if they later resume therapy with the same drugs. ### Why Other Options Are Less Common as Primary Causes - **MDR-TB:** Present in ~2–3% of new TB cases; it is a consequence of poor adherence, not the primary cause of initial failure - **Malabsorption:** Uncommon unless there is overt GI disease or severe malnutrition - **HIV co-infection:** Increases risk but is not the most frequent cause of failure in the general TB population
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.